Infection Control Effect of Dietary Fluid with Whey Peptide in the Management of Patients with Severe Intracranial Hemorrhage During the Acute Stage

Takafumi Shimogawa, Takato Morioka, Noriko Hagiwara, Tomoaki Akiyama, Tetsuro Sayama, Sei Haga, Yoshihiko Furuta, Kei Murao, Yuka Kanazawa, Shuji Arakawa

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

BACKGROUND AND PURPOSE: Patients with severe intracranial hemorrhage (ICH) often develop infectious complications during the acute stage. Animal experiments have demonstrated that enteral immunonutrition with a dietary fluid containing whey peptide (WP) enhances immunoactivity and prevents infection. The aim of the current study was to investigate the infection control effect of WP in the clinical management of patients with severe ICH.

METHODS: Fourteen patients with ICH were given enteral nutrition from January 2012 to December 2012. Nine patients were given WP (WP group) and the other five were given control dietary fluid (Non-WP group) for two weeks. We retrospectively analyzed the incidence of infectious complications and chronological changes in white blood cell (WBC) count, C-reactive protein (CRP), and total lymphocyte count.

RESULTS: All patients in the Non-WP Group experienced infectious complications, whereas 5 out of 9 patients in the WP Group did not experience them. There was a tendency for a decrease in WBC count and CRP value in the WP group. In contrast, WBC and CRP increased in 3 patients in the Non-WP Group. Total lymphocyte count tended to increase earlier in the WP Group; however this tendency was not noted in the Non-WP Group.

CONCLUSION: Although the number of cases was small, our study suggests that WP might have an infection control effect, capable of preventing infectious complications associated with severe ICH in the acute stage.

Original languageEnglish
Pages (from-to)302-307
Number of pages6
JournalFukuoka igaku zasshi = Hukuoka acta medica
Volume106
Issue number11
Publication statusPublished - Nov 1 2015

Fingerprint

Intracranial Hemorrhages
Infection Control
Peptides
C-Reactive Protein
Lymphocyte Count
Leukocyte Count
Whey
Enteral Nutrition
Small Intestine
Leukocytes

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Infection Control Effect of Dietary Fluid with Whey Peptide in the Management of Patients with Severe Intracranial Hemorrhage During the Acute Stage. / Shimogawa, Takafumi; Morioka, Takato; Hagiwara, Noriko; Akiyama, Tomoaki; Sayama, Tetsuro; Haga, Sei; Furuta, Yoshihiko; Murao, Kei; Kanazawa, Yuka; Arakawa, Shuji.

In: Fukuoka igaku zasshi = Hukuoka acta medica, Vol. 106, No. 11, 01.11.2015, p. 302-307.

Research output: Contribution to journalArticle

Shimogawa, T, Morioka, T, Hagiwara, N, Akiyama, T, Sayama, T, Haga, S, Furuta, Y, Murao, K, Kanazawa, Y & Arakawa, S 2015, 'Infection Control Effect of Dietary Fluid with Whey Peptide in the Management of Patients with Severe Intracranial Hemorrhage During the Acute Stage', Fukuoka igaku zasshi = Hukuoka acta medica, vol. 106, no. 11, pp. 302-307.
Shimogawa, Takafumi ; Morioka, Takato ; Hagiwara, Noriko ; Akiyama, Tomoaki ; Sayama, Tetsuro ; Haga, Sei ; Furuta, Yoshihiko ; Murao, Kei ; Kanazawa, Yuka ; Arakawa, Shuji. / Infection Control Effect of Dietary Fluid with Whey Peptide in the Management of Patients with Severe Intracranial Hemorrhage During the Acute Stage. In: Fukuoka igaku zasshi = Hukuoka acta medica. 2015 ; Vol. 106, No. 11. pp. 302-307.
@article{cbfa2b1c78e7419191b334a19bfeda7e,
title = "Infection Control Effect of Dietary Fluid with Whey Peptide in the Management of Patients with Severe Intracranial Hemorrhage During the Acute Stage",
abstract = "BACKGROUND AND PURPOSE: Patients with severe intracranial hemorrhage (ICH) often develop infectious complications during the acute stage. Animal experiments have demonstrated that enteral immunonutrition with a dietary fluid containing whey peptide (WP) enhances immunoactivity and prevents infection. The aim of the current study was to investigate the infection control effect of WP in the clinical management of patients with severe ICH.METHODS: Fourteen patients with ICH were given enteral nutrition from January 2012 to December 2012. Nine patients were given WP (WP group) and the other five were given control dietary fluid (Non-WP group) for two weeks. We retrospectively analyzed the incidence of infectious complications and chronological changes in white blood cell (WBC) count, C-reactive protein (CRP), and total lymphocyte count.RESULTS: All patients in the Non-WP Group experienced infectious complications, whereas 5 out of 9 patients in the WP Group did not experience them. There was a tendency for a decrease in WBC count and CRP value in the WP group. In contrast, WBC and CRP increased in 3 patients in the Non-WP Group. Total lymphocyte count tended to increase earlier in the WP Group; however this tendency was not noted in the Non-WP Group.CONCLUSION: Although the number of cases was small, our study suggests that WP might have an infection control effect, capable of preventing infectious complications associated with severe ICH in the acute stage.",
author = "Takafumi Shimogawa and Takato Morioka and Noriko Hagiwara and Tomoaki Akiyama and Tetsuro Sayama and Sei Haga and Yoshihiko Furuta and Kei Murao and Yuka Kanazawa and Shuji Arakawa",
year = "2015",
month = "11",
day = "1",
language = "English",
volume = "106",
pages = "302--307",
journal = "Fukuoka Acta Medica",
issn = "0016-254X",
publisher = "福岡医学会",
number = "11",

}

TY - JOUR

T1 - Infection Control Effect of Dietary Fluid with Whey Peptide in the Management of Patients with Severe Intracranial Hemorrhage During the Acute Stage

AU - Shimogawa, Takafumi

AU - Morioka, Takato

AU - Hagiwara, Noriko

AU - Akiyama, Tomoaki

AU - Sayama, Tetsuro

AU - Haga, Sei

AU - Furuta, Yoshihiko

AU - Murao, Kei

AU - Kanazawa, Yuka

AU - Arakawa, Shuji

PY - 2015/11/1

Y1 - 2015/11/1

N2 - BACKGROUND AND PURPOSE: Patients with severe intracranial hemorrhage (ICH) often develop infectious complications during the acute stage. Animal experiments have demonstrated that enteral immunonutrition with a dietary fluid containing whey peptide (WP) enhances immunoactivity and prevents infection. The aim of the current study was to investigate the infection control effect of WP in the clinical management of patients with severe ICH.METHODS: Fourteen patients with ICH were given enteral nutrition from January 2012 to December 2012. Nine patients were given WP (WP group) and the other five were given control dietary fluid (Non-WP group) for two weeks. We retrospectively analyzed the incidence of infectious complications and chronological changes in white blood cell (WBC) count, C-reactive protein (CRP), and total lymphocyte count.RESULTS: All patients in the Non-WP Group experienced infectious complications, whereas 5 out of 9 patients in the WP Group did not experience them. There was a tendency for a decrease in WBC count and CRP value in the WP group. In contrast, WBC and CRP increased in 3 patients in the Non-WP Group. Total lymphocyte count tended to increase earlier in the WP Group; however this tendency was not noted in the Non-WP Group.CONCLUSION: Although the number of cases was small, our study suggests that WP might have an infection control effect, capable of preventing infectious complications associated with severe ICH in the acute stage.

AB - BACKGROUND AND PURPOSE: Patients with severe intracranial hemorrhage (ICH) often develop infectious complications during the acute stage. Animal experiments have demonstrated that enteral immunonutrition with a dietary fluid containing whey peptide (WP) enhances immunoactivity and prevents infection. The aim of the current study was to investigate the infection control effect of WP in the clinical management of patients with severe ICH.METHODS: Fourteen patients with ICH were given enteral nutrition from January 2012 to December 2012. Nine patients were given WP (WP group) and the other five were given control dietary fluid (Non-WP group) for two weeks. We retrospectively analyzed the incidence of infectious complications and chronological changes in white blood cell (WBC) count, C-reactive protein (CRP), and total lymphocyte count.RESULTS: All patients in the Non-WP Group experienced infectious complications, whereas 5 out of 9 patients in the WP Group did not experience them. There was a tendency for a decrease in WBC count and CRP value in the WP group. In contrast, WBC and CRP increased in 3 patients in the Non-WP Group. Total lymphocyte count tended to increase earlier in the WP Group; however this tendency was not noted in the Non-WP Group.CONCLUSION: Although the number of cases was small, our study suggests that WP might have an infection control effect, capable of preventing infectious complications associated with severe ICH in the acute stage.

UR - http://www.scopus.com/inward/record.url?scp=84975152324&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975152324&partnerID=8YFLogxK

M3 - Article

C2 - 27044137

AN - SCOPUS:84975152324

VL - 106

SP - 302

EP - 307

JO - Fukuoka Acta Medica

JF - Fukuoka Acta Medica

SN - 0016-254X

IS - 11

ER -